Literature DB >> 29442522

The impact of PTSD clusters on cannabis use in a racially diverse trauma-exposed sample: An analysis from ecological momentary assessment.

Julia D Buckner1, Emily R Jeffries1, Ross D Crosby2,3, Michael J Zvolensky4,5, Courtenay E Cavanaugh6, Stephen A Wonderlich2,3.   

Abstract

BACKGROUND: Accumulating evidence indicates a link between post-traumatic stress disorder (PTSD) and cannabis use and suggests that this link may vary as a function of the PTSD symptom cluster type. Consistent with negative reinforcement models of substance use, individuals with elevated Cluster D (Hyperarousal) symptoms may be more likely to use cannabis in response to elevated state anxiety and experience decreases in state anxiety after using cannabis.
OBJECTIVES: We aimed to test hypotheses that the interaction of Cluster D and state anxiety would be related to subsequent cannabis use and that those with elevated Cluster D symptoms who used cannabis would report the greatest decreases in state anxiety. To test the specificity, we tested whether Clusters B (re-experiencing) and C (avoidance) showed similar relationships.
METHODS: The present study used ecological momentary assessment to examine cannabis use among 87 cannabis-using individuals with PTSD symptoms (64.4% male, 56.3% non-Hispanic Caucasian). State anxiety and cannabis use were assessed over the two-week period via signal contingent (six random prompts per day), interval contingent (each bedtime), and event contingent (cannabis use episodes) assessments.
RESULTS: Consistent with negative reinforcement models, participants with clinically significant Cluster D symptoms with elevated state anxiety had a greater likelihood of subsequent cannabis use and cannabis use resulted in less subsequent anxiety. The negative reinforcement hypothesis was only partially supported for those with Cluster B and C symptoms.
CONCLUSIONS: The results suggest that negative reinforcement models may be especially relevant to understanding cannabis use among those with clinically elevated Cluster D symptoms.

Entities:  

Keywords:  Cannabis; ecological momentary assessment; marijuana; negative reinforcement; post-traumatic stress

Mesh:

Year:  2018        PMID: 29442522      PMCID: PMC6294292          DOI: 10.1080/00952990.2018.1430149

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  45 in total

Review 1.  Addiction motivation reformulated: an affective processing model of negative reinforcement.

Authors:  Timothy B Baker; Megan E Piper; Danielle E McCarthy; Matthew R Majeskie; Michael C Fiore
Journal:  Psychol Rev       Date:  2004-01       Impact factor: 8.934

2.  Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study.

Authors:  James W Hopper; Zhaohui Su; Alison R Looby; Elizabeth T Ryan; David M Penetar; Christopher M Palmer; Scott E Lukas
Journal:  Drug Alcohol Depend       Date:  2006-05-30       Impact factor: 4.492

3.  Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma.

Authors:  Naomi Breslau; Glenn C Davis; Lonni R Schultz
Journal:  Arch Gen Psychiatry       Date:  2003-03

4.  The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program.

Authors:  Kristi-Ann Villagonzalo; Seetal Dodd; Felicity Ng; Stephen Mihaly; Amy Langbein; Michael Berk
Journal:  Compr Psychiatry       Date:  2010-12-15       Impact factor: 3.735

5.  The mediating roles of coping, sleep, and anxiety motives in cannabis use and problems among returning veterans with PTSD and MDD.

Authors:  Jane Metrik; Kristina Jackson; Shayna S Bassett; Michael J Zvolensky; Karen Seal; Brian Borsari
Journal:  Psychol Addict Behav       Date:  2016-10-27

6.  Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from Ecological Momentary Assessment.

Authors:  Julia D Buckner; Michael J Zvolensky; Ross D Crosby; Stephen A Wonderlich; Anthony H Ecker; Ashley Richter
Journal:  Drug Alcohol Depend       Date:  2014-12-31       Impact factor: 4.492

7.  Cell phones for ecological momentary assessment with cocaine-addicted homeless patients in treatment.

Authors:  Michelle J Freedman; Kristin M Lester; Cecelia McNamara; Jesse B Milby; Joseph E Schumacher
Journal:  J Subst Abuse Treat       Date:  2006-03

8.  Daily mood patterns and bulimic behaviors in the natural environment.

Authors:  Ross D Crosby; Stephen A Wonderlich; Scott G Engel; Heather Simonich; Joshua Smyth; James E Mitchell
Journal:  Behav Res Ther       Date:  2008-12-27

9.  Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse.

Authors:  J D Bremner; S M Southwick; A Darnell; D S Charney
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

10.  Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.

Authors:  A Neumeister; M D Normandin; R H Pietrzak; D Piomelli; M Q Zheng; A Gujarro-Anton; M N Potenza; C R Bailey; S F Lin; S Najafzadeh; J Ropchan; S Henry; S Corsi-Travali; R E Carson; Y Huang
Journal:  Mol Psychiatry       Date:  2013-05-14       Impact factor: 15.992

View more
  3 in total

1.  PTSD Symptom Clusters and Craving Differs by Primary Drug of Choice.

Authors:  Vanessa C Somohano; Kristoffer L Rehder; Tyree Dingle; Taylor Shank; Sarah Bowen
Journal:  J Dual Diagn       Date:  2019-07-14

2.  Intraindividual association of PTSD symptoms with binge drinking among trauma-exposed students.

Authors:  Lance M Rappaport; Shannon E Cusack; Christina M Sheerin; Ananda B Amstadter
Journal:  J Couns Psychol       Date:  2021-03-25

3.  Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.

Authors:  Laura Orsolini; Stefania Chiappini; Umberto Volpe; Domenico De Berardis; Roberto Latini; Gabriele Duccio Papanti; And John Martin Corkery
Journal:  Medicina (Kaunas)       Date:  2019-08-23       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.